Sexual transmission is associated with spontaneous HCV clearance in HIV-infected patients

Journal of Hepatology

Volumn 49, Issue 3, 2008, Pages 323-328

  Shores, Nathan J ^a   Maida, Ivana ^b,c   Soriano, Vincent ^c   Núňez, Marina ^d  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF SASSARI   (Italy)

^c HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^d WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

Author keywords

Coinfection; HBV; HCV; HIV; Injection drug use; Intravenous drug use; Sexual transmission; Spontaneous clearance

Indexed keywords

HEPATITIS B SURFACE ANTIBODY; VIRUS ANTIBODY; VIRUS RNA;

ADULT; ARTICLE; CALCULATION; CLEARANCE; COMORBIDITY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DRUG USE; FEMALE; HEPATITIS B; HEPATITIS C; HEPATITIS C VIRUS; HETEROSEXUALITY; HOSPITAL ADMISSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INFECTION RISK; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; RACE DIFFERENCE; RETROSPECTIVE STUDY; RISK FACTOR; SEX DIFFERENCE; SEXUAL TRANSMISSION; STATISTICAL SIGNIFICANCE;

ADULT; CROSS-SECTIONAL STUDIES; EUROPE; FEMALE; HEPACIVIRUS; HEPATITIS C; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS; RISK-TAKING; RNA, VIRAL; SEXUALLY TRANSMITTED DISEASES, VIRAL; SUBSTANCE ABUSE, INTRAVENOUS; TIME FACTORS; UNITED STATES;

EID: 48449105419     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2008.04.010     Document Type: Article

References (36)

1. Hoofnagle J.H. Hepatitis C: the clinical spectrum of disease. Hepatology 26 (1997) 15S-20S
2. Alter M.J., Kruszon-Moran D., Nainan O.V., McQuillan G.M., Gao F., Moyer L.A., et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 341 (1999) 556-562
3. Fleming C.A., Craven D.E., Thornton D., Tumilty S., and Nunes D. Hepatitis C virus and human immunodeficiency virus coinfection in an urban population: low eligibility for interferon treatment. Clin Infect Dis 36 (2003) 97-100
4. Grebely J., Conway B., Raffa J.D., Lai C., Krajden M., and Tyndall M.W. Hepatitis C virus reinfection in injection drug users. Hepatology 44 (2006) 1139-1145
5. Melendez-Morales L., Konkle B.A., Preiss L., Zhang M., Mathew P., Eyster M.E., et al. Chronic hepatitis B and other correlates of spontaneous clearance of hepatitis C virus among HIV-infected people with hemophilia. Aids 21 (2007) 1631-1636
6. Mendes-Correa M.C., Barone A.A., and Guastini C. Hepatitis C virus seroprevalence and risk factors among patients with HIV infection. Rev Inst Med Trop Sao Paulo 43 (2001) 15-19
7. Messick K., Sanders J.C., Goedert J.J., and Eyster M.E. Hepatitis C viral clearance and antibody reactivity patterns in persons with haemophilia and other congenital bleeding disorders. Haemophilia 7 (2001) 568-574
8. Mussi A.D., Pereira R.A., Silva V.D., Martins R.M., and Souto F.J. Epidemiological aspects of hepatitis C virus infection among HIV-infected individuals in Mato Grosso State, Central Brazil. Acta Trop 104 (2007) 116-121
9. Perez-Cano R., Fernandez-Gutierrez C., Lopez-Suarez A., Mira J., and Giron-Gonzalez J.A. Factors related to the chronicity and evolution of hepatitis C infection in patients co-infected by the human immunodeficiency virus. Clin Microbiol Infect 8 (2002) 589-597
10. Quarleri J.F., Bolcic F.M., Bouzas M.B., Laufer N., Gomez Carrillo M., Mammana L., et al. HCV genotype distribution among HIV co-infected individuals in Argentina: relationship with host and viral factors. Acta Gastroenterol Latinoam 37 (2007) 76-83
11. Sherman K.E., Rouster S.D., Chung R.T., and Rajicic N. Hepatitis C virus prevalence among patients infected with human immunodeficiency virus: a cross-sectional analysis of the US adult AIDS clinical trials group. Clin Infect Dis 34 (2002) 831-837
12. Jauncey M., Micallef J.M., Gilmour S., Amin J., White P.A., Rawlinson W., et al. Clearance of hepatitis C virus after newly acquired infection in injection drug users. J Infect Dis 190 (2004) 1270-1274
13. Watanabe H., Saito T., Shinzawa H., Okumoto K., Hattori E., Adachi T., et al. Spontaneous elimination of serum hepatitis C virus (HCV) RNA in chronic HCV carriers: a population-based cohort study. J Med Virol 71 (2003) 56-61
14. Maida I., Soriano V., Ramos B., Rios P., Gonzalez-Lahoz J., and Nunez M. Characteristics and prospects for hepatitis C therapy of an HIV-HCV coinfected population followed at a reference HIV center. HIV Clin Trials 6 (2005) 329-336
15. Micallef J.M., Kaldor J.M., and Dore G.J. Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies. J Viral Hepatol 13 (2006) 34-41
16. Grebely J., Raffa J.D., Lai C., Krajden M., Conway B., and Tyndall M.W. Factors associated with spontaneous clearance of hepatitis C virus among illicit drug users. Can J Gastroenterol 21 (2007) 447-451
17. Seal K.H., Monto A., Dove L., Shen H., Vittinghoff E., Tracy D., et al. The association of human immunodeficiency virus infection with spontaneously resolved hepatitis C virus infection and level of viremia among injection drug users. Dig Dis Sci 52 (2007) 3423-3430
18. Zhang M., Rosenberg P.S., Brown D.L., Preiss L., Konkle B.A., Eyster M.E., et al. Correlates of spontaneous clearance of hepatitis C virus among people with hemophilia. Blood 107 (2006) 892-897
19. Morsica G., Bagaglio S., Ghezzi S., Lodrini C., Vicenzi E., Santagostino E., et al. Hepatitis C virus (HCV) coinfection in a cohort of HIV positive long-term non-progressors: possible protective effect of infecting HCV genotype on HIV disease progression. J Clin Virol 39 (2007) 82-86
20. Zeitoun J.D., Mallet V., Chaix M.L., Viard J.P., Blanche S., and Pol S. Stable recovery from HCV in HIV-HCV co-infection under antiretroviral therapy. J Clin Virol 40 (2007) 71-73
21. Matthews G.V., Hellard M., Kaldor J., Lloyd A., and Dore G.J. Further evidence of HCV sexual transmission among HIV-positive men who have sex with men: response to Danta et al. Aids 21 (2007) 2112-2113
22. Di Martino V., Rufat P., Boyer N., Renard P., Degos F., Martinot-Peignoux M., et al. The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: a long-term retrospective cohort study. Hepatology 34 (2001) 1193-1199
23. Pawlotsky J.M., Chevaliez S., and McHutchison J.G. The hepatitis C virus life cycle as a target for new antiviral therapies. Gastroenterology 132 (2007) 1979-1998
24. Barth H., Liang T.J., and Baumert T.F. Hepatitis C virus entry: molecular biology and clinical implications. Hepatology 44 (2006) 527-535
25. Danta M., Brown D., Bhagani S., Pybus O.G., Sabin C.A., Nelson M., et al. Recent epidemic of acute hepatitis C virus in HIV-positive men who have sex with men linked to high-risk sexual behaviours. Aids 21 (2007) 983-991
26. van de Laar T.J., van der Bij A.K., Prins M., Bruisten S.M., Brinkman K., Ruys T.A., et al. Increase in HCV incidence among men who have sex with men in Amsterdam most likely caused by sexual transmission. J Infect Dis 196 (2007) 230-238
27. Neaigus A., Gyarmathy V.A., Zhao M., Miller M., Friedman S.R., and Des Jarlais D.C. Sexual and other noninjection risks for HBV and HCV seroconversions among noninjecting heroin users. J Infect Dis 195 (2007) 1052-1061
28. Lissen E., Alter H.J., Abad M.A., Torres Y., Perez-Romero M., Leal M., et al. Hepatitis C virus infection among sexually promiscuous groups and the heterosexual partners of hepatitis C virus infected index cases. Eur J Clin Microbiol Infect Dis 12 (1993) 827-831
29. Rai R.R., Mathur A., Mathur D., Udawat H.P., Nepalia S., Nijhawan S., et al. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission. Trop Gastroenterol 28 (2007) 19-23
30. Yenigun A., and Durupinar B. Decreased frequency of the HLA-DRB1*11 allele in patients with chronic hepatitis C virus infection. J Virol 76 (2002) 1787-1789
31. Thio C.L., Thomas D.L., Goedert J.J., Vlahov D., Nelson K.E., Hilgartner M.W., et al. Racial differences in HLA class II associations with hepatitis C virus outcomes. J Infect Dis 184 (2001) 16-21
32. Zavaglia C., Martinetti M., Silini E., Bottelli R., Daielli C., Asti M., et al. Association between HLA class II alleles and protection from or susceptibility to chronic hepatitis C. J Hepatol 28 (1998) 1-7
33. Cramp M.E., Carucci P., Underhill J., Naoumov N.V., Williams R., and Donaldson P.T. Association between HLA class II genotype and spontaneous clearance of hepatitis C viraemia. J Hepatol 29 (1998) 207-213
34. Zavaglia C., Bortolon C., Ferrioli G., Rho A., Mondazzi L., Bottelli R., et al. HLA typing in chronic type B, D and C hepatitis. J Hepatol 24 (1996) 658-665
35. Hohler T., Gerken G., Notghi A., Knolle P., Lubjuhn R., Taheri H., et al. MHC class II genes influence the susceptibility to chronic active hepatitis C. J Hepatol 27 (1997) 259-264
36. Ksiaa L., Ayed-Jendoubi S., Sfar I., Gorgi Y., Najjar H.A., Abdallah T.B., et al. Clearance and persistence of hepatitis C virus in a Tunisian population: association with HLA class I and class II. Viral Immunol 20 (2007) 312-319